- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Trends in Pharmacological Sciences, 45, 6, S. 475-477
- Event
-
Veröffentlichung
- (where)
-
Augsburg
- (who)
-
Universität Augsburg
- (when)
-
2024
- Event
-
Veröffentlichung
- (who)
-
Elsevier BV
- (when)
-
2024
- Creator
- DOI
-
10.1016/j.tips.2024.04.011
- URN
-
urn:nbn:de:bvb:384-opus4-1130960
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Noeparast, Maxim
- Timofeev, Oleg
- Pichler, Martin
- Universität Augsburg
- Elsevier BV
Time of origin
- 2024
Other Objects (12)
Prediction of response in melanoma therapy by systemic inflammatory response – one size fits not all
Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-magnitude of clinical benefit scale (ESMO-MCBS) version 1.1
So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt
A case report of immediate effects of acupuncture on neuropathic cancer breakthrough pain
Best of ASCO 2022: bladder cancer
Mapping the clinical practice of traditional, complementary and integrative medicine in oncology in Western countries: a multinational cross-sectional survey
Role of non-coding RNAs in modulating the response of cancer cells to paclitaxel treatment
Tumor macroenvironment and metabolism
MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients
Inflammation, phagocytosis and cancer: another step in the CD47 act
Epidermal growth factor receptor inhibitors in adjuvant treatment of lung cancer — the more specific, the better?
Non-smoking-associated lung cancer: a distinct entity in terms of tumor biology, patient characteristics and impact of hereditary cancer predisposition
Prediction of response in melanoma therapy by systemic inflammatory response – one size fits not all
Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-magnitude of clinical benefit scale (ESMO-MCBS) version 1.1
So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt
A case report of immediate effects of acupuncture on neuropathic cancer breakthrough pain
Best of ASCO 2022: bladder cancer
Mapping the clinical practice of traditional, complementary and integrative medicine in oncology in Western countries: a multinational cross-sectional survey
Role of non-coding RNAs in modulating the response of cancer cells to paclitaxel treatment
Tumor macroenvironment and metabolism
MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients
Inflammation, phagocytosis and cancer: another step in the CD47 act
Epidermal growth factor receptor inhibitors in adjuvant treatment of lung cancer — the more specific, the better?
Non-smoking-associated lung cancer: a distinct entity in terms of tumor biology, patient characteristics and impact of hereditary cancer predisposition
Prediction of response in melanoma therapy by systemic inflammatory response – one size fits not all
Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-magnitude of clinical benefit scale (ESMO-MCBS) version 1.1
So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt
A case report of immediate effects of acupuncture on neuropathic cancer breakthrough pain
Best of ASCO 2022: bladder cancer
Mapping the clinical practice of traditional, complementary and integrative medicine in oncology in Western countries: a multinational cross-sectional survey
Role of non-coding RNAs in modulating the response of cancer cells to paclitaxel treatment
Tumor macroenvironment and metabolism
MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients
Inflammation, phagocytosis and cancer: another step in the CD47 act
Epidermal growth factor receptor inhibitors in adjuvant treatment of lung cancer — the more specific, the better?